SuperworthElicio Therapeutics shares outstanding ELTX
Diluted shares outstanding, averaged over each quarter, from 2020.
- Latest quarter, to Jun 30, 2026
- 19.2M
- On a year earlier
- +19.8%
- more shares
Elicio Therapeutics had 19.2M diluted shares outstanding on average in Q2 FY26, the quarter to Jun 30, 2026.
That is 19.8% more than a year earlier, so each share owns a little less of the company.
Shares outstanding over time
Fiscal year by fiscal year
| Fiscal year | Shares, fourth quarter | Change |
|---|---|---|
| FY2025 | 15.5M | +14% |
| FY2024 | 13.6M | +60% |
| FY2023 | 8.5M | +2557% |
| FY2022 | 320.1K | −89% |
| FY2021 | 3M | +97% |
| FY2020 | 1.5M | n/a |
Each fiscal year is the twelve months to its fourth quarter, shown as the fourth quarter's average share count.
Quarter by quarter
| Quarter | Ended | Shares outstanding | On a year earlier |
|---|---|---|---|
| Q2 FY26 | 19.2M | +20% | |
| Q1 FY26 | 18.2M | +41% | |
| Q4 FY25 | 15.5M | +14% | |
| Q3 FY25 | 16.7M | +23% | |
| Q2 FY25 | 16.1M | +42% | |
| Q1 FY25 | 13M | +26% | |
| Q4 FY24 | 13.6M | +60% | |
| Q3 FY24 | 13.6M | +62% | |
| Q2 FY24 | 11.3M | +290% | |
| Q1 FY24 | 10.3M | +3070% | |
| Q4 FY23 | 8.5M | +2557% | |
| Q3 FY23 | 8.4M | +2538% |
What the shares outstanding tells you
Diluted shares outstanding, averaged over the period. Fewer shares means each one owns more of the company.
A falling count usually means buybacks. A rising one means stock pay, acquisitions paid in shares or new shares sold.
More on Elicio Therapeutics
Valuation data, not investment advice. Prices as of . Reported figures come from the company's filings with the SEC.